MeSH term
Frequency | Condition_Probility | Amino Acid Substitution | 2 | 0.0 |
Female | 53 | 0.0 |
Humans | 102 | 0.0 |
Male | 50 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Reference Values | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 42 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Adult | 25 | 0.0 |
*Aneuploidy | 2 | 2.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Lymphocytes/cytology | 2 | 2.0 |
Metaphase | 2 | 1.0 |
*Polymorphism, Genetic | 18 | 0.0 |
*Preimplantation Diagnosis | 5 | 33.0 |
Telomere/genetics | 2 | 3.0 |
Alleles | 18 | 0.0 |
Blood Group Antigens/*genetics | 9 | 8.0 |
Cluster Analysis | 3 | 1.0 |
Ethnic Groups/*genetics | 4 | 2.0 |
Gene Frequency | 24 | 0.0 |
Haplotypes | 4 | 0.0 |
Phenotype | 26 | 0.0 |
Abortion, Spontaneous/genetics | 4 | 66.0 |
*Chromosome Aberrations | 3 | 0.0 |
Fertilization in Vitro | 4 | 3.0 |
Pregnancy | 12 | 0.0 |
*Translocation, Genetic | 5 | 0.0 |
Trisomy | 2 | 1.0 |
Child, Preschool | 4 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Chromosome Mapping | 13 | 0.0 |
Chromosomes, Human, Pair 1/*genetics | 3 | 1.0 |
Homozygote | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Genes, Structural | 2 | 0.0 |
Genetic Markers | 17 | 0.0 |
Genotype | 3 | 0.0 |
Enzymes/*genetics | 6 | 14.0 |
Erythrocytes/*enzymology | 15 | 2.0 |
Genetic Markers/*genetics | 2 | 1.0 |
*Genetics, Population | 11 | 3.0 |
Italy | 7 | 1.0 |
Polymorphism, Genetic/*genetics | 4 | 0.0 |
Chromosome Disorders | 4 | 1.0 |
English Abstract | 12 | 0.0 |
Netherlands | 2 | 1.0 |
Preimplantation Diagnosis/*methods | 3 | 16.0 |
Comparative Study | 19 | 0.0 |
Spain | 3 | 0.0 |
*Variation (Genetics) | 3 | 0.0 |
*Gene Pool | 3 | 15.0 |
Heterozygote | 8 | 0.0 |
Russia | 4 | 4.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
Demography | 2 | 1.0 |
Ecuador | 2 | 18.0 |
Emigration and Immigration | 2 | 4.0 |
Enzymes/genetics | 4 | 12.0 |
*Gene Frequency | 11 | 2.0 |
Phylogeny | 3 | 0.0 |
Karyotyping | 5 | 0.0 |
Treatment Outcome | 3 | 0.0 |
*Embryonic Development | 2 | 10.0 |
Middle Aged | 10 | 0.0 |
Animals | 17 | 0.0 |
Hamsters | 6 | 0.0 |
Phosphogluconate Dehydrogenase/genetics | 6 | 23.0 |
Adolescent | 10 | 0.0 |
Blood Proteins/*genetics | 10 | 6.0 |
*Genetic Markers | 8 | 2.0 |
HLA Antigens/*genetics | 2 | 0.0 |
Histocompatibility Testing | 2 | 0.0 |
Polymorphism, Genetic | 14 | 0.0 |
Siberia | 3 | 7.0 |
Child | 12 | 0.0 |
Phosphogluconate Dehydrogenase/*genetics | 7 | 58.0 |
ABO Blood-Group System/genetics | 4 | 9.0 |
Acid Phosphatase/genetics | 2 | 6.0 |
Adenosine Deaminase/genetics | 2 | 9.0 |
Aged | 6 | 0.0 |
Infant, Newborn | 3 | 0.0 |
False Negative Reactions | 2 | 1.0 |
False Positive Reactions | 2 | 0.0 |
Mosaicism | 2 | 2.0 |
*Prenatal Diagnosis | 3 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Blood Group Antigens/genetics | 5 | 8.0 |
European Continental Ancestry Group/*genetics | 3 | 0.0 |
Europe | 2 | 0.0 |
Blood Proteins/genetics | 6 | 10.0 |
Erythrocytes/enzymology | 4 | 1.0 |
Gene Frequency/*genetics | 2 | 1.0 |
Phosphogluconate Dehydrogenase/blood/*genetics | 3 | 50.0 |
Variation (Genetics) | 2 | 0.0 |
*Ethnic Groups | 3 | 2.0 |
Linkage (Genetics) | 7 | 0.0 |
Lod Score | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Blood Protein Electrophoresis | 2 | 1.0 |
Phosphogluconate Dehydrogenase/blood/genetics | 2 | 40.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
*Chromosome Mapping | 7 | 0.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Isoenzymes/*genetics | 2 | 0.0 |
*Linkage (Genetics) | 8 | 0.0 |
Pedigree | 5 | 0.0 |
Gene Frequency/genetics | 2 | 0.0 |
Asian Continental Ancestry Group/*genetics | 3 | 0.0 |
*Carboxylesterase | 4 | 3.0 |
Carboxylic Ester Hydrolases/genetics | 3 | 10.0 |
Genetic Markers/genetics | 2 | 0.0 |
Variation (Genetics)/*genetics | 2 | 0.0 |
Hybrid Cells | 4 | 0.0 |
Isoenzymes | 2 | 1.0 |
Mice | 4 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
USSR | 3 | 16.0 |
Isoenzymes/genetics | 2 | 0.0 |
Lactoylglutathione Lyase/genetics | 2 | 4.0 |
Phosphoglucomutase/genetics | 4 | 8.0 |
European Continental Ancestry Group/genetics | 6 | 0.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
Lactoylglutathione Lyase/*genetics | 2 | 4.0 |
Oxidoreductases/*genetics | 2 | 2.0 |
Hydrolases/*genetics | 2 | 8.0 |
Japan | 2 | 0.0 |
Statistics | 2 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
Isoenzymes/blood/*genetics | 2 | 9.0 |
Phosphoglucomutase/*genetics | 3 | 2.0 |
Enzymes/blood/*genetics | 2 | 33.0 |
Electrophoresis | 2 | 0.0 |
Rh-Hr Blood-Group System/genetics | 2 | 7.0 |
Sex Factors | 4 | 0.0 |
*Inuits | 2 | 20.0 |
*Chromosomes, Human, 1-3 | 9 | 15.0 |
Recombination, Genetic | 8 | 0.0 |
Isoenzymes/analysis | 3 | 5.0 |
Rats | 2 | 0.0 |
*Chromosomes, Human, 6-12 and X | 2 | 1.0 |
Phosphopyruvate Hydratase/genetics | 2 | 15.0 |
Rh-Hr Blood-Group System | 3 | 8.0 |
Uridine Kinase/genetics | 2 | 100.0 |
*Blood Group Antigens | 2 | 3.0 |
Duffy Blood-Group System | 2 | 33.0 |
*Genes, Structural | 2 | 0.0 |
*Genes | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Genes | 3 | 1.0 |
Clone Cells | 2 | 0.0 |
Phosphoglucomutase | 2 | 25.0 |
